Table 1 Crude and age-standardized incidence rate of primary CNS tumors according to sex, histological subtype and malignancy statusa
n | % | Crude IR/100,000 | Standardized IR/100000 | |||
|---|---|---|---|---|---|---|
Europe | US | World | ||||
Men | 1526 | 18 | 16 | 16 | 13 | |
Malignancy status | ||||||
Malignant (/3) | 860 | 56 | 9.9 | 9.1 | 9.2 | 7.3 |
Non-malignant (/1, /0) | 666 | 44 | 7.7 | 7.2 | 7.2 | 5.9 |
Histological subtype | ||||||
Neuroepithelial tumors | 843 | 55.2 | 9.7 | 9.1 | 9.1 | 7.3 |
Meningeal tumors | 346 | 22.7 | 4.0 | 3.5 | 3.7 | 2.5 |
Cranial and spinal nerve tumors | 208 | 13.6 | 2.4 | 2.3 | 2.2 | 1.8 |
Lymphomas | 57 | 3.7 | 0.66 | 0.58 | 0.58 | 0.38 |
Other tumors | 72 | 4.7 | 0.83 | 0.77 | 0.82 | 0.72 |
Female | 1989 | 21 | 17 | 17 | 14 | |
Malignancy status | ||||||
Malignant (/3) | 688 | 35 | 7.3 | 5.9 | 5.9 | 4.6 |
Non-malignant (/1, /0) | 1301 | 65 | 14 | 12 | 12 | 9.1 |
Histological subtype | ||||||
Neuroepithelial tumors | 653 | 32.8 | 6.9 | 5.8 | 5.8 | 4.9 |
Meningeal tumors | 975 | 49.0 | 10.4 | 8.4 | 8.4 | 6.5 |
Cranial and spinal nerve tumors | 214 | 10.8 | 2.3 | 2.1 | 2.0 | 1.7 |
Lymphomas | 58 | 2.9 | 0.62 | 0.45 | 0.47 | 0.35 |
Other tumors | 89 | 4.5 | 0.94 | 0.72 | 0.77 | 0.68 |
All | 3515 | 19 | 17 | 17 | 13 | |
Malignancy status | ||||||
Malignant (/3) | 1548 | 44 | 8.6 | 7.4 | 7.4 | 5.9 |
Non-malignant (/1, /0) | 1967 | 56 | 11 | 9.5 | 9.6 | 7.6 |
Histological subtype | ||||||
Neuroepithelial tumors | 1496 | 42.5 | 8.3 | 7.4 | 7.3 | 6.1 |
Meningeal tumors | 1321 | 37.6 | 7.3 | 6.1 | 6.2 | 4.5 |
Cranial and spinal nerve tumors | 422 | 12.0 | 2.3 | 2.2 | 2.1 | 1.8 |
Lymphomas | 115 | 3.3 | 0.64 | 0.51 | 0.52 | 0.37 |
Other tumors | 161 | 4.6 | 0.89 | 0.75 | 0.80 | 0.70 |